- TrovaGene (TROV): Q2 EPS of -$0.34 misses by $0.03.
- Revenue of $0.1M (+100.0% Y/Y) misses by $0.17M.
- Press Release
TrovaGene misses by $0.03, misses on revenue
Recommended For You
More Trending News
About CRDF Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CRDF | - | - |
| Cardiff Oncology, Inc. | ||